|
Market Closed -
Nasdaq
02:30:00 18/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.1510 USD | +4.07% |
|
-16.85% | -84.90% |
| Market Cap | 98.35L 89.28L 82.47L 74.4L 1.4Cr 92Cr 1.46Cr 9.94Cr 3.93Cr 50Cr 3.69Cr 3.61Cr 156.66Cr | P/E 2026 * |
-0.18x | P/E 2027 * | -0.21x |
|---|---|---|---|---|---|
| Enterprise Value | 98.35L 89.28L 82.47L 74.4L 1.4Cr 92Cr 1.46Cr 9.94Cr 3.93Cr 50Cr 3.69Cr 3.61Cr 156.66Cr | EV / Sales 2026 * |
3.76x | EV / Sales 2027 * | 5.9x |
| Free-Float |
93.35% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TCRX | Delayed | |
| TCRX | Real-time |
Last Transcript: TScan Therapeutics, Inc.
| 1 day | +4.07% | ||
| 1 week | -16.85% | ||
| Current month | -13.47% | ||
| 1 month | -34.63% | ||
| 3 months | -80.61% | ||
| 6 months | -84.90% | ||
| Current year | -84.90% |
| 1 week | 0.14 | 0.19 | |
| 1 month | 0.14 | 0.24 | |
| Current year | 0.14 | 1.47 | |
| 1 year | 0.14 | 1.47 | |
| 3 years | 0.14 | 9.69 | |
| 5 years | 0.14 | 9.69 | |
| 10 years | 0.14 | 14.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin MacBeath
CEO | Chief Executive Officer | 56 | 28/03/2023 |
Dawn Pinchasik
CTO | Chief Tech/Sci/R&D Officer | - | 06/02/2024 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Katina Dorton
BRD | Director/Board Member | 68 | 23/03/2021 |
Gavin MacBeath
BRD | Director/Board Member | 56 | 24/05/2023 |
Stephen Biggar
CHM | Chairman | 55 | 12/06/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/10/26 | Free | Chief Executive Officer | 10,00,000 | 1.5747% | ||
| 01/10/26 | Free | General Counsel | 3,00,000 | 0.4724% | ||
| 20/05/26 | Free | Director | 67,000 | 0.1200% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.07% | -16.85% | -86.27% | -96.82% | 98.35L | ||
| +1.15% | -2.81% | +53.73% | +71.00% | 6.56TCr | ||
| -2.64% | +0.07% | +9.57% | +89.87% | 6.04TCr | ||
| -1.07% | +0.55% | +21.79% | +87.66% | 5.58TCr | ||
| +0.48% | -0.98% | +12.97% | +118.46% | 4.7TCr | ||
| -2.69% | -7.62% | +16.77% | +25.79% | 4.36TCr | ||
| -0.70% | +1.43% | +14.05% | +45.20% | 3.67TCr | ||
| -2.50% | -18.72% | +140.13% | +665.60% | 3.61TCr | ||
| -0.77% | -4.34% | +79.27% | +59.47% | 3.29TCr | ||
| -0.83% | +4.96% | -36.93% | +398.61% | 2.7TCr | ||
| Average | -0.55% | -3.54% | +22.51% | +146.48% | 4TCr | |
| Weighted average by Cap. | -0.99% | -1.48% | +34.17% | +148.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 26.19L 23.78L 21.96L 19.81L 37.41L 24Cr 38.84L 2.65Cr 1.05Cr 13Cr 98.26L 96.19L 42Cr | 16.67L 15.13L 13.98L 12.61L 23.8L 16Cr 24.72L 1.68Cr 66.61L 8.4Cr 62.53L 61.22L 27Cr |
| Net income | -11Cr -10Cr -9.55Cr -8.62Cr -16Cr -1.06TCr -17Cr -115.09Cr -46Cr -574.21Cr -43Cr -42Cr -1.81TCr | -8.26Cr -7.5Cr -6.93Cr -6.25Cr -12Cr -772.11Cr -12Cr -84Cr -33Cr -416.64Cr -31Cr -30Cr -1.32TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | $0.1592 | +9.72% | 3,06,558 |
| 16/26/16 | $0.1451 | -9.65% | 4,04,948 |
| 13/26/13 | $0.1606 | -4.40% | 2,27,685 |
| 12/26/12 | $0.1680 | -9.48% | 7,14,485 |
| 11/26/11 | $0.1856 | +0.22% | 2,92,700 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- TCRX Stock
Select your edition
All financial news and data tailored to specific country editions
















